Test Code HPCOV Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2), Molecular Detection, Varies
Ordering Guidance
Due to the nonspecific clinical presentation of COVID-19 during the early stages of the illness, testing for other respiratory infections (eg, influenza) may be warranted. If this test is ordered with HPFLU / Influenza Virus Type A and Type B and Respiratory Syncytial Virus (RSV) RNA, Molecular Detection, PCR, Varies, then both tests will be canceled and automatically reordered by the laboratory as SCOF4 / Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2), Influenza Virus Type A and Type B RNA, and Respiratory Syncytial Virus (RSV) Molecular Detection, PCR, Varies.
Specimen Required
Preferred:
Specimen Type: Nasopharyngeal swab
Container/Tube: Sterile container with viral transport media
Specimen Volume: Entire specimen with a minimum of 1.5 mL (maximum 3 mL) of transport media.
Collection Instructions:
1. Collect specimen by swabbing back and forth over mucosa surface to maximize recovery of cells.
2. Swab must be placed into viral transport media (eg, M4-RT, M4 or M5), saline, or phosphate buffered saline (PBS). Media should not contain guanidine thiocyanate (GTC).
Specimen Type: Bronchoalveolar lavage fluid
Container/Tube: Sterile container
Specimen Volume: 0.6 mL
Additional Information: Do not aliquot into viral transport media.
Acceptable:
Specimen Type: Oropharyngeal (throat) swab, nasal mid-turbinate, or nares/nasal swab
Supplies:
-Culturette (BBL Culture Swab) (T092)
-Swab, Sterile Polyester (T507)
Collection Container/Tube:
Preferred: BBL Culture Swab or COPAN Mid-turbinate Swab
Acceptable: Dacron-tipped swab with plastic handle
Submission Container/Tube: Swab in sterile container with transport media
Specimen Volume: Entire specimen with a minimum of 1.5 mL (maximum 3 mL) of transport media.
Collection Instructions: Swab must be placed into viral transport media (eg, M4-RT, M4, or M5), saline, or PBS. Media should not contain guanidine thiocyanate (GTC).
Specimen Type: Bronchial washings, endotracheal aspirate, sputum
Container/Tube: Sterile container
Specimen Volume: 0.6 mL
Additional Information: Do not aliquot into viral transport media.
Useful For
Diagnosis of COVID-19 illness due to SARS-CoV-2
Reporting Name
SARS CoV-2 RNA, PCR, VariesSpecimen Type
VariesSpecimen Minimum Volume
Upper respiratory tract swab: See Specimen Required; lower respiratory specimens: 0.3 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Varies | Frozen (preferred) | 14 days |
| Refrigerated | 72 hours |
Reject Due To
| Bloody specimen | Reject |
| Calcium alginate-tipped swab | Reject |
| Wooden shaft swab | Reject |
| Dry swab | Reject |
| Glass transport media tubes | Reject |
| Transport swab containing gel or charcoal additive | Reject |
| Sample tubes containing guanidine isothiocyanate, guanidine thiocyanate, or guanidine hydrochloride | Reject |
Reference Values
Undetected
Method Description
Specimens are transferred first to a specimen lysis tube, which lyses the cells, releases target nucleic acid, and protects them from degradation during storage. The internal control-S (IC-S) is added to each test specimen and control via the working Panther Fusion capture reagent-S. The IC-S in the reagent monitors all aspects of the testing process, including nucleic acid capture, elution, amplification, and detection. Capture oligonucleotides hybridize to nucleic acid in the test specimen. Hybridized nucleic acid is then separated from the specimen in a magnetic field. Wash steps purify the hybridized nucleic acid by removing extraneous components from the reaction tube. The resulting purified nucleic acid is then isolated during the elution step.
During the elution transfer step, purified nucleic acid is transferred to a Panther Fusion reaction tube already containing reconstituted master mix overlaid with oil reagent. Amplification of the target sequences occurs via real-time reverse transcription polymerase chain reaction. A reverse transcriptase generates a DNA copy of the target sequences. Target-specific forward and reverse primers and probes amplify and detect 2 regions of the orf1ab gene of SARS-CoV-2 in conjunction with the internal control. The amplified orf1ab target products are detected on the ROX channel, while the internal control is detected on RED677. The assay software compares the viral target and internal control fluorescence signals to predetermined cut-off values to produce a qualitative result for the presence or absence of the virus.(Instruction manual: SARS-CoV-2 Assay [Panther Fusion System]. AW-21159-001. Hologic, Inc; Rev. 006. 05/2022)
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 to 2 daysSpecimen Retention Time
4 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
CPT Code Information
87635
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| HPCOV | SARS CoV-2 RNA, PCR, Varies | 94559-2 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 614021 | SARS CoV-2 RNA, PCR | 94559-2 |
| HPCVS | SARS CoV-2 RNA, PCR, Source | 31208-2 |
Testing Algorithm
For information see Coronavirus Disease 2019 (COVID-19), Influenza, and Respiratory Syncytial Virus Testing Algorithm.